P1.05-064 Global Practice Patterns of Multifocal Lung Cancer
Aaron S. Mansfield(Mayo Clinic), Dennis A. Wigle(Mayo Clinic), Mark S. Allen(Institut für Sozialforschung und Sozialwirtschaft), Konstantinos Leventakos(Rutgers, The State University of New Jersey), Robert Shen(Mayo Clinic), Julian R. Molina, Christopher L. Hallemeier(Mayo Clinic in Arizona), John J. Mullon(Mayo Clinic in Arizona), Randolph S. Marks(Mayo Clinic), David E. Midthun(Mayo Clinic), Stephen D. Cassivi(Mayo Clinic), Shanda H. Blackmon(The University of Texas MD Anderson Cancer Center), Ping Yang(Milken Institute), Charles F. Thomas(Mayo Clinic), Eric S. Edell(Mayo Clinic), Tobias Peikert(Mayo Clinic in Arizona), Marie Christine Aubry(Mayo Clinic), Yolanda Garces(Mayo Clinic), Francis Nichols(Mayo Clinic in Florida), Sarah Kratz(Mayo Clinic), Alex A. Adjei(Cleveland Clinic), William Holland(Mayo Clinic in Florida)
Cited by 0
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
|Journal of Clinical Oncology|2021|818
Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals
|Annals of the American Thoracic Society|2018|723